Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Stockwatch: Supporting acts to the rescue

This article was originally published in Scrip

Executive Summary

Three months ago, the resounding take-home message from the full year 2010 financial results three months ago was that the environment had not been good and caution surrounded 2011. That theme was mollified during the last week of April when a large number of biotech and pharmaceutical companies, big and small, reported better than expected first quarter 2011 financial results. However, reading between their (sales) lines, it was often not the pharmaceutical divisions amongst pharmaceutical companies that have snatched a recovery from the jaws of last year’s defeat.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts